Most previous studies ([@b6-ehp-118-1229]; [@b30-ehp-118-1229], [@b31-ehp-118-1229]; [@b32-ehp-118-1229]; [@b49-ehp-118-1229]), but not all ([@b41-ehp-118-1229]), that have investigated the triggering of myocardial infarction (MI) by particulate matter (PM) air pollution concentrations in the hours and days before MI onset have reported an association. Other studies have reported increased mortality due to MI or increased mortality or cardiovascular admissions among MI survivors associated with increases in PM over the previous few days ([@b2-ehp-118-1229]; [@b44-ehp-118-1229]; [@b50-ehp-118-1229]). Several studies have investigated whether certain subgroups are particularly susceptible and have reported increased cardiovascular effects among those with diabetes ([@b8-ehp-118-1229]; [@b11-ehp-118-1229]; [@b20-ehp-118-1229]; [@b27-ehp-118-1229]; [@b47-ehp-118-1229]) and among patients with chronic obstructive pulmonary disease (COPD) ([@b26-ehp-118-1229]; [@b49-ehp-118-1229]; [@b51-ehp-118-1229]). However, [@b49-ehp-118-1229] reported increased susceptibility among patients with COPD but not among persons with diabetes.

Numerous researchers have reported that the percentage of infarctions that are nontransmural has been increasing ([@b9-ehp-118-1229]; [@b14-ehp-118-1229]; [@b18-ehp-118-1229]; [@b25-ehp-118-1229]; [@b36-ehp-118-1229], [@b37-ehp-118-1229]; [@b38-ehp-118-1229]). More recently, [@b39-ehp-118-1229] noted a similar secular trend in clinical presentation of MI to emergency departments (EDs) in New Jersey. In short, 72% of persons admitted to hospitals in New Jersey from 1990 through 1992 for MI had had transmural infarctions, and only 28% had had nontransmural infarctions. Since then, however, this pattern has reversed. From 2002 through 2004, most of the admissions for MI were for nontransmural infarctions (63%), with only 37% for transmural infarctions ([@b39-ehp-118-1229]). These changes may be due in part to improvements in preventive pharmacotherapies (statins, beta blockers, aspirin), interventional procedures \[angioplasty, coronary artery bypass graft (CABG)\], more sensitive diagnostic tests (troponins), and treatment of the MI upon ED arrival (reperfusion therapy, increased use of antiplatelet agents). It has not been reported whether PM with aerodynamic diameter ≤ 2.5 μm (PM~2.5~) triggers all infarctions, whether PM--MI associations differ in magnitude, or whether these associations are restricted to PM--transmural or PM--nontransmural infarctions alone. Such investigations may provide insight into the mechanisms by which PM may trigger cardiovascular events.

Using the same data as [@b39-ehp-118-1229], we attempted to replicate, in New Jersey, previous MI--PM~2.5~ studies that were conducted in other U.S. and European cities. We hypothesized that increases in mean PM~2.5~ concentration on the same day and a few days before ED arrival for MI may be associated with increased risk of MI and that these effect estimates would be greater for persons with diabetes and those with COPD than for individuals without these conditions. Further, we explored whether there were differences in risks associated with increases in ambient PM~2.5~ concentration between transmural and nontransmural infarctions.

Materials and Methods
=====================

Study population and outcome definition
---------------------------------------

Using the Myocardial Infarction Data Acquisition System (MIDAS), a statewide surveillance system in New Jersey that combines hospital discharge data and death certificate registration data ([@b17-ehp-118-1229], [@b16-ehp-118-1229]), we extracted all records with a primary diagnosis of acute MI \[*International Classification of Diseases*, version 9 (ICD-9), codes 410.01, 410.11, 410.21, 410.31, 410.41, 410.51, 410.61, 410.71, 410.81, and 410.91\] for patients who were admitted between 1 January 2004 and 31 December 2006, were ≥ 18 years of age, were residents of New Jersey at the time of their MI, and who were without a previous diagnosis of MI (ICD-9 code 412). Because the "1" in the fifth digit of the ICD-9 code (e.g., 410.01) indicates a first MI for the subject, we also used this designation to exclude those persons who had had a previous MI. Those who were not admitted into the hospital (e.g., patient declined admission, patient died before admission) were not included in this data set. We classified patients with an MI coded as 410.7 (subendocardial infarction) as having a nontransmural infarction, and those with codes 410.0 (infarction of anterolateral wall), 410.1 (infarction of other anterior wall), 410.2 (infarction of inferolateral wall), 410.3 (infarction of inferoposterior wall), 410.4 (infarction of other inferior wall), 410.5 (infarction of other lateral wall), and 410.6 (true posterior wall infarction) as having transmural infarctions.

From these extracted data, we also retained the following variables: date and hour of ED admission; ZIP code of residence; age; sex; race; variables indicating the presence or absence of other comorbid conditions (based on ICD-9 codes)---congestive heart failure (ICD-9 code 428.0), arrhythmia (ICD-9 codes 426.0, 426.10, 426.12, 426.2, 426.3, 426.4, 426.5, 426.6, 426.89, 426.9, and 427), hypertension (ICD-9 codes 401--405), diabetes (ICD-9 code 250), COPD (ICD-9 codes 490--496), and history of ischemic heart disease (ICD-9 codes 410--414); and variables indicating in-hospital and postinfarction procedures (based on ICD-9 code)---angioplasty, CABG, and catheterization.

This study and the original MIDAS study were approved by the University of Medicine and Dentistry of New Jersey--New Brunswick Institutional Review Board. MIDAS was also approved by the New Jersey Department of Health and Senior Services Institutional Review Board.

Air pollution
-------------

Using ambient pollutant measurements from the New Jersey Department of Environmental Protection and from U.S. Environmental Protection Agency (EPA) Web sites ([@b43-ehp-118-1229]), we used hourly concentrations of PM~2.5~ (7 monitoring stations), nitrogen dioxide (NO~2~; 9 stations), sulfur dioxide (SO~2~; 14 stations), carbon monoxide (CO; 13 stations), and ozone (O~3~; 15 stations) for the study period 1 January 2004 to 31 December 2006. For each patient, we calculated the distance between each PM~2.5~ monitor (in operation at the time of the MI) and the patient's residence and assigned PM~2.5~ measurements from the closest monitor to their residence. Those patients who lived \> 10 km from a PM~2.5~ monitoring station were excluded from PM~2.5~ analyses. We calculated mean PM~2.5~ concentrations for each successive 24-hr period before ED arrival for the MI (e.g., mean of hours 0--23 before ED arrival; 24--47 mean of hours before ED arrival, etc.). If \> 6 hr (\> 25%) of a 24-hr period of PM~2.5~ concentrations were missing, we set the mean for this 24-hr period of PM~2.5~ concentration to missing. We used these mean concentrations in all analyses. We repeated this monitor matching and mean concentration calculation process for each of the other pollutants.

Weather
-------

Hourly temperature and dew point measurements were made at the Newark, Caldwell, Somerset, and Trenton, New Jersey, airports during the study period. We used the airport monitor closest to each patient's residence to provide the weather observations for that patient during the study period. After calculating 24-hr mean temperature and dew point, in the same manner as for the pollutant concentrations, we calculated 24-hr mean apparent temperature ([@b40-ehp-118-1229]; [@b49-ehp-118-1229]) as a measure of each patient's perceived air temperature given the humidity and used these values in all analyses.

Study design
------------

We used a time-stratified case-crossover design ([@b19-ehp-118-1229]; [@b23-ehp-118-1229]) that has previously been used in studies of ambient air pollution and MI ([@b6-ehp-118-1229]; [@b32-ehp-118-1229]; [@b41-ehp-118-1229]; [@b49-ehp-118-1229]), as well as other cardiovascular outcomes ([@b35-ehp-118-1229], [@b33-ehp-118-1229], [@b34-ehp-118-1229]; [@b46-ehp-118-1229]). In this design, each patient contributed information as a case during the period immediately before the MI and as a matched control during times when an MI did not occur. The case-crossover design is analogous to a matched case--control study, but instead of estimating the relative risk of MI comparing exposure between persons (i.e., cases vs. controls), we estimated the relative risk of MI comparing exposure during different time periods within the follow-up time of each case of MI. Because case periods and their matched control periods are derived from the same person and a conditional analysis is conducted, non-time--varying confounders such as age, comorbidities, and history of long-term smoking were controlled by the study design. However, variables that may be related to both air pollution and the incidence of MI that vary over short time periods, such as weather conditions, which vary day to day, were possible confounders and were included in our analytic models. Case periods were defined as the 24-hr period before ED admission for MI, whereas control periods (three or four per case depending on the number of days in the calendar month) were matched to the case period by day of the week, time of the day, year, and month. For example, if a person arrived at the ED with an MI at exactly 0000 hours on 20 March 2009, then the 24-hr case period was the prior 24 hr (0000 hours to 2359 hours on Thursday 19 March), and the control periods were 0000 hours to 2359 hours on the three previous Thursdays (5, 12, and 26 March 2009). Pollutant concentrations corresponding to these case and control periods were contrasted in all analyses.

Main analysis
-------------

Using a conditional logistic regression model stratified on each MI (one case and three or four control periods), we regressed case--control status (i.e., case period = 1, control period = 0) against the mean PM~2.5~ concentration in the 24 hr before ED arrival. Using Akaike's information criterion to select the optimal lag time and number of degrees of freedom for apparent temperature, we also included a natural spline (3 degrees of freedom) of the mean apparent temperature in the 48 hr before ED arrival in the model. We then reran this same model, replacing the 24-hr mean PM~2.5~ concentration (for both case and control periods) with one of six lagged mean PM~2.5~ concentrations (i.e., mean of hours 24--47, 48--71, 72--95, 96--119, 120--143, or 144--167 before ED arrival) to estimate the risk of MI associated with each lagged PM~2.5~ concentration. From each model, we present the odds ratio (OR) and its 95% confidence interval (CI) scaled to the interquartile range (IQR) of PM~2.5~ observed during the study period. A *p*-value \< 0.05 was used to indicate statistical significance.

Next, we examined whether the risk of MI associated with an IQR increase in mean PM~2.5~ concentration in the 24 hr before ED arrival was different for patients with transmural versus nontransmural infarctions. We reran the same model described above for patients with transmural infarctions only, and then for patients with nontransmural infarctions only. To examine potential effect modification by other factors, including COPD, diabetes, age (\< 65 years, ≥ 65 years), sex, race (white, black, other), and season (winter = December, January, February; summer = June, July, August), we used an interaction term (e.g., COPD × PM~2.5~) in the main model.

Sensitivity analyses
--------------------

To assess the stability of our PM~2.5~ relative risk estimates after adjusting for gaseous pollutant concentrations, we created two-pollutant models (PM~2.5~ + NO~2~, PM~2.5~ + CO, PM~2.5~ + SO~2~, PM~2.5~ + O~3~) using mean pollutant concentrations from the 24 hr before ED arrival. We also evaluated whether any association between ED arrival for MI and the mean PM~2.5~ concentration in the previous 24 hr was independent of concentrations from previous 24-hr periods. We reran the same conditional logistic regression model described above, including all seven lagged PM~2.5~ concentrations (i.e., the mean PM~2.5~ concentrations from the 24 hr before ED arrival for MI, and the mean concentrations from the previous six lagged 24-hr periods).

All data sets included in the analyses were constructed using SAS software (version 9.1.3; SAS Institute Inc., Cary, NC), and all analyses were conducted using R (version 2.6.1; R Foundation for Statistical Computing, Vienna, Austria). The authors had full access to the data and take responsibility for its integrity.

Results
=======

During the study period, a total of 37,791 patients were admitted to nonfederal New Jersey hospitals for a first acute MI; of these, 5,864 lived within 10 km of a PM~2.5~ monitoring site and had PM~2.5~ data available for analysis (i.e., PM~2.5~ data available for at least 18 of the 24 hr before ED arrival for the index MI). Study patients were predominantly older (59% \> 65 years of age), white (69%), and male (56%). Sixty-two percent had hypertension, 61% had a history of ischemic heart disease, and 30% had diabetes ([Table 1](#t1-ehp-118-1229){ref-type="table"}). Those who were excluded from our analysis were similar to persons who were included in age (61% \> 65 years of age), sex (57% male), and comorbidities (e.g., 59% with hypertension), but they were slightly more likely to be white (82%). Subjects included in the analysis who experienced a nontransmural infarction were generally older and were more likely to have had cardiorespiratory comorbidities than were those who experienced a transmural infarction. Compared with the subjects who had a nontransmural infarction, those who had a transmural infarction were more likely to have had an angioplasty and/or catheterization postinfarction but less likely to have had CABG ([Table 1](#t1-ehp-118-1229){ref-type="table"}). Of note, there were seven monitors that made PM~2.5~ measurements in 2006 but only three in 2004 and 2005, which resulted in a larger number of patients living within 10 km of a PM~2.5~ monitoring site and thus available for analysis in 2006 ([Table 2](#t2-ehp-118-1229){ref-type="table"}).

Of the seven monitors that were continuously measuring PM~2.5~ during the study period, patients were most often assigned to the Elizabeth Lab (32%), Camden Lab (26%), and New Brunswick (18%) monitors. The distribution of mean daily PM~2.5~ concentrations at each of these seven monitors is shown in [Table 2](#t2-ehp-118-1229){ref-type="table"}. When combining all the monitors, PM~2.5~ concentrations had a median of 11.7 μg/m^3^; 5th and 95th percentiles of 3.6 and 31.5 μg/m^3^, respectively; and 25th and 75th percentiles of 7.4 and 18.3 μg/m^3^, respectively (IQR = 10.8 μg/m^3^). We scaled all our effect estimates presented below by this IQR. [Table 3](#t3-ehp-118-1229){ref-type="table"} shows Pearson correlation coefficients for individual pollutants and apparent temperature.

Next, we separately estimated the risk of ED admission for MI associated with each IQR increase in the mean PM~2.5~ concentration in the previous 24 hr, and lagged 24-hr periods (hours 24--47, 48--71, 72--95, 96--119, 120--143, and 144--167), adjusting for apparent temperature during that same lag period. Each 10.8-μg/m^3^ increase in the mean PM~2.5~ concentration in the 24 hr before ED arrival was not associated with an increased risk of MI ([Table 4](#t4-ehp-118-1229){ref-type="table"}). Similarly, we found no associations between ED admission for overall MI and any of the lagged PM~2.5~ concentrations. However, when we then restricted our analysis to transmural infarctions only we found a significantly increased risk associated with each 10.8-μg/m^3^ increase in PM~2.5~ concentration in the previous 24 hr (OR = 1.10; 95% CI, 1.01--1.20). When examining lagged PM~2.5~ concentrations, the relative risk estimates were mostly \> 1.0, but none was statistically significant. In contrast, when we restricted our analysis to nontransmural infarctions, we found no increased risks associated with any lagged PM~2.5~ concentrations ([Table 4](#t4-ehp-118-1229){ref-type="table"}).

Because we found an association with transmural infarctions only, we restricted all further analyses to this infarction type and evaluated whether several factors modified this association. Patients with preexisting COPD and those \< 65 years of age had substantially larger risks of transmural infarction associated with each 10.8 μg/m^3^ increase in PM~2.5~ concentration in the previous 24 hr than did patients without preexisting COPD and those ≥ 65 years of age ([Table 5](#t5-ehp-118-1229){ref-type="table"}). We found no difference in PM~2.5~ relative risk estimates by race, sex, season, or whether subjects had diabetes ([Table 5](#t5-ehp-118-1229){ref-type="table"}).

We then included mean PM~2.5~ and NO~2~ concentrations from the 24 hr before ED arrival simultaneously in a model (*n* = 1,262 patients with transmural infarctions with both PM~2.5~ and NO~2~ mean concentrations). The PM~2.5~ relative risk estimate in this two-pollutant model was not substantially different from the single-pollutant model on the same *n* = 1,262 patients ([Table 6](#t6-ehp-118-1229){ref-type="table"}). This was also true when adjusting for CO, SO~2~, and O~3~. IQR increases in CO, SO~2~, and O~3~ were not associated with significantly increased risks of transmural infarctions in any single- or two-pollutant model ([Table 6](#t6-ehp-118-1229){ref-type="table"}). Next, when including all seven lagged PM~2.5~ concentrations in the same model, the risk associated with the 24-hr moving-average PM~2.5~ concentration was larger and still statistically significant (OR = 1.15; 95% CI, 1.04--1.28). All the PM~2.5~ concentration relative risk estimates for the other lag periods were smaller than the 24-hr moving-average relative risk estimate, and none was statistically significant (data not shown).

Discussion
==========

Using a large multiyear (2004--2006) statewide data set of hospital admissions for first MI, we found no association between admission for MI overall and PM~2.5~ concentrations in the previous week. However, when we restricted the analysis to patients with transmural infarctions, we found a significant 10% increase in the risk of a transmural infarction associated with the mean PM~2.5~ concentration in the 24 hr before ED arrival. This association persisted with adjustment for gaseous pollutant concentrations in the prior 24 hr and with adjustment for PM~2.5~ concentrations during each of the previous six 24-hr periods. Further, patients with COPD, but not diabetes, were particularly susceptible to acute increases in ambient PM~2.5~ concentrations. We found no association with this same PM~2.5~ concentration and nontransmural infarctions.

Our findings are consistent with previous studies ([@b6-ehp-118-1229]; [@b30-ehp-118-1229]; [@b31-ehp-118-1229]; [@b32-ehp-118-1229]; [@b49-ehp-118-1229]) in indicating an acute association between PM and MI onset, although the method of estimating MI onset time (day of hospital admission for MI, time of symptom onset estimated by patient, etc.), lags of pollutant concentrations examined (lag days 0--6, 0--6 lagged 24-hr periods before ED arrival for MI), and specific particle sizes examined (PM~10~, PM~2.5~) are not uniform. Previous studies reported PM associations with all MIs, not just transmural infarctions ([@b6-ehp-118-1229]; [@b30-ehp-118-1229]; [@b31-ehp-118-1229]; [@b32-ehp-118-1229]; [@b49-ehp-118-1229]). However, these studies drew data from earlier time periods \[e.g., [@b30-ehp-118-1229], Boston, Massachusetts, 1995--1996; [@b31-ehp-118-1229], Augsburg, Germany, 1999--2001; [@b6-ehp-118-1229], Rome, Italy, 1995--1997; [@b49-ehp-118-1229], 21 U.S. cities, 1985--1999)\] when most infarctions were likely transmural. Therefore, their reports of increased relative risk of MI are consistent with our finding of increased relative risk of transmural infarctions only. Thus, our study adds to the body of knowledge that relates increased risk of MI with increases in PM in the previous hours and days, but ours is the first to report that associations are restricted to transmural infarctions.

Pathophysiologic pathways proposed as mechanisms underlying previously reported PM/MI associations include systemic inflammation, endothelial dysfunction, disturbance of autonomic tone, and enhanced coagulation/thrombosis ([@b3-ehp-118-1229]). Our finding of an acute (within 24 hr) association between PM and transmural infarctions, but not nontransmural infarctions, suggests another mechanism or pathway, perhaps related to those listed above, by which particles may trigger an MI. In a recent study, [@b1-ehp-118-1229] reported decreased myocardial blood flow in canines associated with concentrated air particles exposure, but not with filtered air exposure, after experimental occlusion of the coronary artery. Cardiac work was not increased by PM in this dog model, and data suggested that blood flow reductions were due to increased coronary vascular resistance, perhaps related to more limited recruitment of collateral vessels. Thus, particle inhalation, by reducing compensatory mechanisms, may transform limited (nontransmural) injury into more extensive (transmural) infarction. This finding is consistent with other research in which PM has been associated with increased rates of ST-segment depression in humans ([@b10-ehp-118-1229]; [@b29-ehp-118-1229]) or in canine model markers of ischemia ([@b45-ehp-118-1229]). There is also increasing support in the literature for the prothrombotic effects of air pollutants that indicates the possibility that limitations in revascularization after a primary plaque-related thrombotic event could be due to enhanced thrombosis in general ([@b5-ehp-118-1229]; [@b15-ehp-118-1229]; [@b22-ehp-118-1229]). A recent study that examined the association between PM and acute coronary events demonstrated greater relative risk in those individuals with angiographically documented previous coronary disease ([@b32-ehp-118-1229]). Future analyses using data from MIDAS will include examining differences in susceptibility to PM by prior disease events, including MI.

Ambient PM has previously been associated with increased hospital admissions for COPD and asthma ([@b4-ehp-118-1229]; [@b7-ehp-118-1229]; [@b24-ehp-118-1229]; [@b28-ehp-118-1229]; [@b48-ehp-118-1229]). COPD is associated with a greater propensity to hypoxia, reduced pulmonary reserve, and a generally heightened inflammatory state, which all may predispose to transmural infarcts.

Although several researchers have reported acute associations between PM and cardiovascular outcomes in panels of patients with diabetes or have reported greater changes in cardiorespiratory biomarkers among those with diabetes than those without diabetes ([@b8-ehp-118-1229]; [@b11-ehp-118-1229]; [@b20-ehp-118-1229]; [@b27-ehp-118-1229]; [@b47-ehp-118-1229]), we did not find greater susceptibility to PM among patients with diabetes. Similar to the findings of [@b49-ehp-118-1229], we found larger relative risks for patients with COPD than for those without this condition, but no difference in relative risk estimates for patients with diabetes versus those without diabetes.

Although our study has several strengths, including a large sample size, with subcategories of infarct and availability of continuous PM~2.5~ concentrations from seven monitoring stations during the study period, several limitations should be considered when interpreting our results. First, this study relies on administrative data only, and therefore some of the outcomes coded as an MI may not have been an MI, or those classified as transmural may have been miscoded as nontransmural, or vice versa. Specifically, we were limited to only ICD-9 codes to classify an MI as a transmural or nontransmural. However, a data audit was previously conducted that verified the accuracy of MI diagnoses as well as the accuracy of information in the MIDAS data set ([@b16-ehp-118-1229]). Thus, any outcome misclassification (MI vs. non-MI) was likely minimal. Further, any misclassification of transmural versus nontransmural was likely unrelated to ambient PM~2.5~ concentrations, resulting in nondifferential exposure misclassification and underestimates of relative risk.

Second, our data set included only those subjects who experienced an MI and were admitted to a hospital, and excluded MI patients who died before hospital admission. If PM does trigger transmural infarctions, which might have a higher out-of-hospital mortality rate, our data set would include a lower number of PM-triggered transmural infarctions than actually occurred during the study period. Therefore, our estimate of a 10% increase in the risk of a transmural infarction associated with each 10.8 μg/m^3^ increase in PM~2.5~ may be conservative.

Third, linking MIs to hourly and daily air pollution fluctuations requires minimizing misclassification of the estimate of MI onset time, so as to minimize bias. Although four previous studies ([@b30-ehp-118-1229]; [@b31-ehp-118-1229]; [@b32-ehp-118-1229]; [@b41-ehp-118-1229]) have used patients' self-reported time of pain and symptom onset, this was not practical for our study, which relied on an administrative data set without personal interviews. Previous studies have reported median and mean delay times from symptom onset to ED arrival of 2.3--4.7 hr ([@b12-ehp-118-1229]), with 44% of MI patients in Massachusetts arriving within 2 hr, and 78% arriving within \< 6 hr ([@b13-ehp-118-1229]). Thus, because there is often a delay of several hours from symptom onset to ED arrival, use of ED arrival hour instead of hour of symptom onset results in greater exposure misclassification and bias toward the null. Further, in our analysis, the mean PM~2.5~ concentrations in the 6, 12, and 24 hr before ED arrival were highly correlated (*r*-values = 0.83--0.95). Therefore, we did not examine associations with ambient PM~2.5~ concentrations \< 24 hr before ED arrival, but instead focused on associations between infarctions and the ambient air pollution concentration in the 24 hr before ED arrival for that MI. Our finding of an association between increased 24-hr mean PM~2.5~ concentrations and transmural infarction needs to be replicated in a study that better estimates MI symptom onset time. This study would also allow a more proper investigation of the risk of a transmural infarction associated with PM~2.5~ concentrations \< 24 hr before MI symptom onset than is possible in our analysis.

Fourth, because all of the 24 hr used to calculate the mean PM~2.5~ concentration in the 24 hr before ED arrival may not have been before the onset of MI symptoms, this again was a source of nondifferential exposure misclassification that may have resulted underestimates of relative risk. As reported by [@b21-ehp-118-1229], this error in estimation of symptom onset time and the resulting relative risk--rate underestimation may be substantial in studies of acute cardiovascular and cerebrovascular events and short-term increases in PM. When comparing relative risk estimates based on symptom onset of stroke versus those based on hospital presentation for stroke, they observed an approximately 40% underestimation of the relative risk of stroke when using time of hospital presentation ([@b21-ehp-118-1229]).

Last, we assigned PM~2.5~ concentrations to all patients who lived \< 10 km from a PM~2.5~ monitor, regardless of how close they lived to the monitor or how much time they spent at locations other than their residence. Because this error is not likely differential with respect to when a patient had the MI, it likely resulted in nondifferential exposure misclassification and underestimates of relative risk. In the two pollutant analyses adjusting for gaseous pollutant concentrations, gaseous pollutants may have greater degrees of spatial variability than does PM~2.5~ within this 10-km radius, resulting in residual confounding.

Conclusions
===========

We found increased risk of transmural infarctions, but not nontransmural infarctions, associated with each 10.8 μg/m^3^ increase in mean PM~2.5~ concentration in the 24 hr before ED arrival. Further, patients with COPD, but not those with diabetes, appeared particularly susceptible to effects of ambient particles. If our findings are confirmed, future investigations of PM and MI triggering should stratify by type of MI, with particular emphasis on transmural infarctions. Future work should also investigate mechanistic explanations for these findings.
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###### 

Frequency and percentage of characteristics of study population (cases matched to PM~2.5~ monitors at ≤ 10 km distance): MIDAS study 2004--2006.

                               Total MI (*n* = 5,864)   Nontransmural MI (*n* = 3,822)   Transmural MI (*n* = 1,563)
  ---------------------------- ------------------------ -------------------------------- -----------------------------
  Age (years)                                                                            
   18--44                      376 (6)                  214 (6)                          137 (9)
   45--54                      842 (14)                 454 (12)                         326 (20)
   55--64                      1,245 (21)               736 (19)                         404 (26)
   65--74                      1,187 (20)               796 (21)                         297 (19)
   75--84                      1,431 (25)               1,027 (27)                       277 (18)
   ≥ 85                        783 (14)                 595 (15)                         122 (8)
                                                                                         
  Sex                                                                                    
   Male                        3,296 (56)               2,048 (54)                       980 (63)
   Female                      2,568 (44)               1,774 (46)                       583 (37)
                                                                                         
  Race                                                                                   
   White                       4,027 (69)               2,625 (69)                       1,079 (69)
   Black                       901 (15)                 623 (16)                         180 (12)
   Other                       936 (16)                 574 (15)                         304 (19)
                                                                                         
  Year                                                                                   
   2004                        1,634 (28)               1,066 (28)                       452 (29)
   2005                        1,523 (26)               994 (26)                         396 (25)
   2006                        2,707 (46)               1,762 (46)                       715 (46)
                                                                                         
  Comorbidity                                                                            
   Hypertension                3,658 (62)               2,506 (66)                       864 (55)
   Diabetes mellitus           1,761 (30)               1,207 (32)                       423 (27)
   Type I diabetes             136 (2)                  103 (3)                          22 (1)
   Type II diabetes            1,625 (28)               1,104 (29)                       401 (26)
   COPD                        839 (14)                 608 (16)                         164 (10)
   Pneumonia                   445 (8)                  350 (9)                          60 (4)
   Heart disease               5,100 (87)               3,373 (88)                       1,326 (85)
    Ischemic heart disease     3,603 (61)               2,285 (60)                       1,052 (67)
    Congestive heart failure   1,878 (32)               1,427 (37)                       299 (19)
    Atrial fibrillation        971 (17)                 723 (19)                         174 (11)
    Arrhythmia                 1,793 (31)               1,177 (31)                       466 (30)
    Ventricular tachycardia    332 (6)                  173 (5)                          129 (8)
                                                                                         
  In-hospital procedure                                                                  
   Angioplasty                 786 (13)                 393 (10)                         350 (22)
   CABG                        288 (5)                  202 (5)                          60 (4)
   Catheterization             3,178 (54)               1,908 (50)                       1,028 (66)

###### 

Distribution of daily mean PM~2.5~ concentrations at each monitoring station used.

  Monitoring station   No. (%) of subjects matched to this monitor   Start and end dates of monitor during study period   No. of nonmissing days   PM~2.5~ concentration (μg/m^3^)                       
  -------------------- --------------------------------------------- ---------------------------------------------------- ------------------------ --------------------------------- ----- ------ ------ ------
  Camden Lab           1,473 (25)                                    January 2004--December 2006                          986                      0.5                               6.7   11.1   17.0   52.2
  Elizabeth Lab        2,009 (34)                                    January 2004--December 2006                          1,052                    0                                 7.1   12.2   18.8   61.0
  Flemington           35 (1)                                        January 2006--December 2006                          259                      0                                 3.9   7.6    12.8   38.4
  Jersey City          661 (11)                                      January 2006--December 2006                          336                      1.4                               6.0   9.7    18.2   46.9
  Millville            148 (3)                                       January 2006--December 2006                          348                      0.6                               6.6   10.3   16.1   48.4
  New Brunswick        1,131 (19)                                    January 2004--December 2006                          1,040                    0.4                               5.9   9.1    14.3   47.0
  Rahway               407 (7)                                       January 2006--December 2006                          246                      5.1                               9.0   12.3   18.3   48.8

###### 

Pearson correlation coefficients for case and control period pollutant concentrations and apparent temperature.

  Pollutant              PM~2.5~   NO~2~   SO~2~   CO      O~3~
  ---------------------- --------- ------- ------- ------- ------
  PM~2.5~                                                  
  NO~2~                  0.44                              
  SO~2~                  0.44      0.56                    
  CO                     0.33      0.63    0.42            
  O~3~                   0.19      −0.41   −0.32   −0.39   
  Apparent temperature   0.35      −0.23   −0.29   −0.11   0.56

###### 

Estimated risk of ED admission for MI (95% CI) associated with each 10.8-μg/m^3^ increase in moving average PM~2.5~ concentration, by infarction type.

  Lag period                  No. of infarctions   OR (95% CI)
  --------------------------- -------------------- -------------------
  All infarctions                                  
   0--23                      5,864                1.02 (0.98--1.07)
   24--47                     5,838                1.01 (0.97--1.06)
   48--71                     5,821                0.99 (0.95--1.04)
   72--95                     5,784                1.01 (0.97--1.05)
   96--119                    5,795                1.02 (0.98--1.07)
   120--143                   5,786                1.00 (0.96--1.05)
   144--167                   5,770                1.00 (0.96--1.04)
  Transmural infarctions                           
   0--23                      1,563                1.10 (1.01--1.20)
   24--47                     1,560                1.02 (0.93--1.11)
   48--71                     1,548                1.04 (0.96--1.13)
   72--95                     1,544                1.03 (0.95--1.12)
   96--119                    1,554                1.05 (0.97--1.13)
   120--143                   1,558                1.04 (0.97--1.13)
   144--167                   1,551                0.97 (0.90--1.05)
  Nontransmural infarctions                        
   0--23                      3,822                0.99 (0.94--1.05)
   24--47                     3,803                1.00 (0.94--1.06)
   48--71                     3,805                0.96 (0.91--1.01)
   72--95                     3,771                0.98 (0.93--1.04)
   96--119                    3,773                1.01 (0.96--1.06)
   120--143                   3,766                0.99 (0.94--1.04)
   144--167                   3,758                1.00 (0.95--1.05)

Each estimate of the risk of MI associated with each IQR increase in lagged PM~2.5~ concentration was modeled separately, adjusting for apparent temperature during that same lag period.

###### 

Risk of ED admission for transmural infarction (and 95% CI) associated with each 10.8-μg/m^3^ increase in the mean PM~2.5~ concentration in the previous 24 hr.

  Characteristic   No. of infarctions   OR (95% CI)         *p*-Value for interaction
  ---------------- -------------------- ------------------- --------------------------------------------------
  COPD                                                      
   Yes             164                  1.32 (1.05--1.66)   0.10
   No              1,399                1.07 (0.98--1.18)   
                                                            
  Diabetes                                                  
   Yes             423                  1.06 (0.90--1.23    0.54
   No              1,140                1.11 (1.01--1.23)   
                                                            
  Age (years)                                               
   \< 65           867                  1.18 (1.05--1.31)   0.05
   ≥ 65            696                  1.01 (0.89--1.14)   
                                                            
  Sex                                                       
   Male            980                  1.12 (1.01--1.24)   0.54
   Female          583                  1.07 (0.94--1.21)   
                                                            
  Race                                                      
   White           1,079                1.11 (1.01--1.23)   ---
   Black           180                  1.14 (0.93--1.41)   0.79[a](#tfn3-ehp-118-1229){ref-type="table-fn"}
   Other           304                  1.02 (0.84--1.23)   0.40[b](#tfn4-ehp-118-1229){ref-type="table-fn"}
                                                            
  Season                                                    
   Winter          345                  1.08 (0.90--1.30)   0.90
   Summer          404                  1.09 (0.94--1.26)   

Each estimate of the risk of MI associated with each IQR increase in lagged PM~2.5~ concentration was modeled separately, adjusting for apparent temperature during that same lag period.

Comparing black with white.

Comparing other with white.

###### 

Risk of transmural infarction (and 95% CI) associated with each IQR increase in mean pollutant concentration in the previous 24 hr.

  Pollutant   Model type         No. of infarctions   OR (95% CI)
  ----------- ------------------ -------------------- -------------------
  PM~2.5~     Single pollutant   1,262                1.10 (1.00--1.21)
  NO~2~       Single pollutant   1.11 (0.97--1.25)    
  PM~2.5~     Two pollutant      1.08 (0.96--1.22)    
  NO~2~       Two pollutant      1.04 (0.88--1.22)    
                                                      
  PM~2.5~     Single pollutant   1,183                1.08 (0.98--1.19)
  CO          Single pollutant   1.02 (0.93--1.12)    
  PM~2.5~     Two pollutant      1.10 (0.98--1.22)    
  CO          Two pollutant      0.97 (0.87--1.08)    
                                                      
  PM~2.5~     Single pollutant   1,238                1.08 (0.98--1.18)
  SO~2~       Single pollutant   1.02 (0.93--1.11)    
  PM~2.5~     Two pollutant      1.10 (0.98--1.24)    
  SO~2~       Two pollutant      0.96 (0.86--1.08)    
                                                      
  PM~2.5~     Single pollutant   1,003                1.08 (0.97--1.21)
  O~3~        Single pollutant   0.95 (0.81--1.12)    
  PM~2.5~     Two pollutant      1.08 (0.97--1.21)    
  O~3~        Two pollutant      0.95 (0.81--1.11)    

IQR = 10.8 μg/m^3^ for PM~2.5~, 16 ppb for NO~2~, 0.35 ppm for CO, 4.1 ppb for SO~2~, and 18 ppb for O~3~.
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